-
Healthcare & Life Sciences
Healthcare providers often find themselves navigating complex political and regulatory challenges, while facing rising demand for efficiency, quality and personalization to vulnerable end-users. Increasingly, patients are becoming less deferential and developing a consumer mindset. Integrating technology into traditional service delivery has both helped and hampered this transition.
CIL has experience across a wide range of products and services in the healthcare market, working with management teams and investors to align their offer with market demand. Our healthcare team regularly draws on the experience of CIL’s other sector practices to offer our clients true cross-sector collaboration and holistic insights into the healthcare market.
Healthcare services: including a range of different business models across all stages of healthcare, from acute and primary care to ongoing support. We also work with businesses in elective treatment and direct-to-consumer segments, such as cosmetics and dentistry.
Social care: this includes care for children, the elderly and the disabled (both physically and mentally) in both residential, supported living and home care settings.
Life sciences: we have a wealth of experience advising businesses across the entire pharmaceutical supply chain, including clinical research (CRO), drug development, manufacturing, outsourcing, regulatory affairs, medical affairs, marketing and distribution.
Animal health: veterinary services (companion and farm animals), nutrition, distribution and other support services.
Support services and products: we also collaborate with our business services, industrials and technology practices to support businesses that provide procurement, staffing, products and equipment, logistics and IT in the healthcare and life sciences sectors.
Healthcare services: including a range of different business models across all stages of healthcare, from acute and primary care to ongoing support. We also work with businesses in elective treatment and direct-to-consumer segments, such as cosmetics and dentistry.
Social care: this includes care for children, the elderly and the disabled (both physically and mentally) in both residential, supported living and home care settings.
Life sciences: we have a wealth of experience advising businesses across the entire pharmaceutical supply chain, including clinical research (CRO), drug development, manufacturing, outsourcing, regulatory affairs, medical affairs, marketing and distribution.
Animal health: veterinary services (companion and farm animals), nutrition, distribution and other support services.
Support services and products: we also collaborate with our business services, industrials and technology practices to support businesses that provide procurement, staffing, products and equipment, logistics and IT in the healthcare and life sciences sectors.
M&A support: we support investors and management teams to determine which deals are worth pursuing and how to optimize the investment.
Growth prioritization: from new service lines, international expansion, and market opportunity, we help businesses to identify, assess and prioritize growth opportunities.
Multi-site roll-out: we work with a range of businesses that provide multi-site healthcare services. We support growth through new site assessments, consolidation analysis and service offering expansion.
Pricing: we help healthcare and life sciences companies to understand their pricing power and unlock hidden margin potential.
User to consumer: power is increasingly shifting toward the patient. We help clients navigate the consequences of this: the proliferation of stakeholders, greater focus on value for money and user experience and less trust in institutions and experts.
M&A support: we support investors and management teams to determine which deals are worth pursuing and how to optimize the investment.
Growth prioritization: from new service lines, international expansion, and market opportunity, we help businesses to identify, assess and prioritize growth opportunities.
Multi-site roll-out: we work with a range of businesses that provide multi-site healthcare services. We support growth through new site assessments, consolidation analysis and service offering expansion.
Pricing: we help healthcare and life sciences companies to understand their pricing power and unlock hidden margin potential.
User to consumer: power is increasingly shifting toward the patient. We help clients navigate the consequences of this: the proliferation of stakeholders, greater focus on value for money and user experience and less trust in institutions and experts.
OK boomer: demographic shifts mean economic opportunity
Major demographic shifts are poised to change the consumer landscape, principal among them, an older and healthier population.
